The DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.
Transcriptional Activation of the Human Glutathione Peroxidase Promoter by p53
Open accessAbstract
Glutathione peroxidase (GPX) is a primary antioxidant enzyme that scavenges hydrogen peroxide or organic hydroperoxides. We have recently found that GPX is induced by etoposide, a topoisomerase II inhibitor and a p53 activator. In a search for a cis-element that confers potential p53 regulation of GPX, we identified a p53 binding site in the promoter of the GPX gene. This site bound to purified p53 as well as p53 in nuclear extract activated by etoposide. A luciferase reporter driven by a 262-base pair GPX promoter fragment was transcriptionally activated by wild type p53 in a p53 binding site-dependent manner. The same reporter was also activated in a p53 binding site-independent manner by several p53 mutants. The p53 binding and transactivation of the GPX promoter were enhanced by etoposide in p53-positive U2-OS cells. Etoposide-induced transactivation was blocked by a dominant negative p53 mutant, indicating that endogenous wild type p53, upon activation by etoposide, transactivated the GPX promoter. Furthermore, expression of endogenous GPX was induced significantly at both mRNA and enzyme activity levels by etoposide in U2-OS cells but not in p53-negative Saos-2 cells. This is the first report demonstrating that GPX is a novel p53 target gene. The finding links the p53 tumor suppressor to an antioxidant enzyme and will facilitate study of the p53 signaling pathway and antioxidant enzyme regulation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase.
Paglia, D. E., & Valentine, W. N. (1967) · PubMed · Cited by 10,889
WAF1, a potential mediator of p53 tumor suppression
El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., & Vogelstein, B. (1993) · Cell · doi:10.1016/0092-8674(93)90500-p · Cited by 8,321
p53, the cellular gatekeeper for growth and division
Levine, A. J. (1997) · Cell · doi:10.1016/s0092-8674(00)81871-1 · Cited by 7,693
Lane, D. P. (1992) · Nature · doi:10.1038/358015a0 · Cited by 5,138
Tumor suppressor p53 is a direct transcriptional activator of the human bax gene
Toshiyuki, M., & Reed, J. C. (1995) · Cell · doi:10.1016/0092-8674(95)90412-3 · Cited by 4,063
Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis.
Greenblatt, M. S., Bennett, W. P., Hollstein, M., & Harris, C. C. (1994) · PubMed · Cited by 3,463
Kastan, M. B., Zhan, Q., El-Deiry, W. S., Carrier, F., Jacks, T., Walsh, W. V., Plunkett, B. S., Vogelstein, B., & Fornace, A. J. (1992) · Cell · doi:10.1016/0092-8674(92)90593-2 · Cited by 3,047
A model for p53-induced apoptosis
Polyak, K., Xia, Y., Zweier, J. L., Kinzler, K. W., & Vogelstein, B. (1997) · Nature · doi:10.1038/38525 · Cited by 2,500
Ko, L. J., & Prives, C. (1996) · Genes & Development · doi:10.1101/gad.10.9.1054 · Cited by 2,344
Definition of a consensus binding site for p53
El-Deiry, W. S., Kern, S. E., Pietenpol, J. A., Kinzler, K. W., & Vogelstein, B. (1992) · Nature Genetics · doi:10.1038/ng0492-45 · Cited by 1,985
Suppression of Human Colorectal Carcinoma Cell Growth by Wild-Type p53
Baker, S. J., Markowitz, S., Fearon, E. R., Willson, J. K. V., & Vogelstein, B. (1990) · Science · doi:10.1126/science.2144057 · Cited by 1,754
A novel form of Epstein-Barr virus latency in normal B cells in vivo
Miyashita, E. M., Yang, B., Lam, K. M. C., Crawford, D. H., & Thorley-Lawson, D. A. (1995) · Cell · doi:10.1016/0092-8674(95)90513-8 · Cited by 1,593
Bax-Deficient Mice with Lymphoid Hyperplasia and Male Germ Cell Death
Knudson, C. M., Tung, K. S. K., Tourtellotte, W. G., Brown, G. A. J., & Korsmeyer, S. J. (1995) · Science · doi:10.1126/science.270.5233.96 · Cited by 1,493
Control of Angiogenesis in Fibroblasts by p53 Regulation of Thrombospondin-1
Dameron, K. M., Volpert, O. V., Tainsky, M. A., & Bouck, N. (1994) · Science · doi:10.1126/science.7521539 · Cited by 1,438
Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53
Livingstone, L. R., White, A., Sprouse, J., Livanos, E., Jacks, T., & Tlsty, T. D. (1992) · Cell · doi:10.1016/0092-8674(92)90243-6 · Cited by 1,332
mdm2 expression is induced by wild type p53 activity.
Barak, Y., Juven, T., Haffner, R., & Oren, M. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05678.x · Cited by 1,290
Yin, Y., Tainsky, M. A., Bischoff, F. Z., Strong, L. C., & Wahl, G. M. (1992) · Cell · doi:10.1016/0092-8674(92)90244-7 · Cited by 1,089
KILLER/DR5 is a DNA damage–inducible p53–regulated death receptor gene
Wu, G. S., Burns, T. F., McDonald, E. R., Jiang, W., Meng, R., Krantz, I. D., Kao, G., Gan, D.-D., Zhou, J.-Y., Muschel, R., et al. (1997) · Nature Genetics · doi:10.1038/ng1097-141 · Cited by 1,083
Free radicals, antioxidant enzymes, and carcinogenesis
Sun, Y. (1990) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(90)90156-d · Cited by 1,062
Self-citationGodwin, A. K., Meister, A., O'Dwyer, P. J., Huang, C. S., Hamilton, T. C., & Anderson, M. E. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.7.3070 · Cited by 925
Regulation of the specific DNA binding function of p53
Hupp, T. R., Meek, D. W., Midgley, C. A., & Lane, D. P. (1992) · Cell · doi:10.1016/0092-8674(92)90562-q · Cited by 909
Mills, G. C. (1957) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)70608-x · Cited by 798
Glutathione : chemical, biochemical, and medical aspects
Dolphin, D., Avramovic-Zikic, O., & Poulson, R. (1989) · Medical Entomology and Zoology · Cited by 754
Modulation of Activity of the Promoter of the Human MDR 1 Gene by Ras and p53
Chin, K.-V., Ueda, K., Pastan, I., & Gottesman, M. M. (1992) · Science · doi:10.1126/science.1346476 · Cited by 726
Chambers, I., Frampton, J., Goldfarb, P., Affara, N., McBain, W., & Harrison, P. R. (1986) · The EMBO Journal · doi:10.1002/j.1460-2075.1986.tb04350.x · Cited by 667
Chu, F. F., Doroshow, J. H., & Esworthy, R. S. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53812-6 · Cited by 553
Inactivation of glutathione peroxidase by superoxide radical
Blum, J., & Fridovich, I. (1985) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(85)90056-6 · Cited by 528
P53, cell cycle control and apoptosis: Implications for cancer
Kastan, M. B., Canman, C. E., & Leonard, C. J. (1995) · Cancer and Metastasis Reviews · doi:10.1007/bf00690207 · Cited by 482
Rearrangement of the p53 gene in human osteogenic sarcomas.
Masuda, H., Miller, C., Koeffler, H. P., Battifora, H., & Cline, M. J. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.21.7716 · Cited by 474
Cyclin G is a transcriptional target of the p53 tumor suppressor protein.
Okamoto, K., & Beach, D. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06807.x · Cited by 455
The role of selenium peroxidases in the protection against oxidative damage of membranes
Ursini, F., & Bindoli, A. (1987) · Chemistry and Physics of Lipids · doi:10.1016/0009-3084(87)90053-3 · Cited by 392
Inactivation of Glutathione Peroxidase by Nitric Oxide
Asahi, M., Fujii, J., Suzuki, K., Seo, H. G., Kuzuya, T., Hori, M., Tada, M., Fujii, S., & Taniguchi, N. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.36.21035 · Cited by 309
Bian, J., & Sun, Y. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.11.6330 · Cited by 276
Self-citationFrank, L., & Groseclose, E. E. (1984) · Pediatric Research · doi:10.1203/00006450-198403000-00004 · Cited by 257
Lane, D. P. (1994) · British Medical Bulletin · doi:10.1093/oxfordjournals.bmb.a072911 · Cited by 195
Transcriptional Activation of the Human Epidermal Growth Factor Receptor Promoter by Human p53
Ludes-Meyers, J. H., Subler, M. A., Shivakumar, C. V., Munoz, R. M., Jiang, P., Bigger, J. E., Brown, D. R., Deb, S. P., & Deb, S. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.11.6009 · Cited by 182
Modulation of cellular and viral promoters by mutant human p53 proteins found in tumor cells
Deb, S., Jackson, C. T., Subler, M. A., & Martin, D. W. (1992) · Journal of Virology · doi:10.1128/jvi.66.10.6164-6170.1992 · Cited by 160
The Protective Role of Glutathione Peroxidase in Apoptosis Induced by Reactive Oxygen Species
Kayanoki, Y., Fujii, J., Islam, K. N., Suzuki, K., Kawata, S., Matsuzawa, Y., & Taniguchi, N. (1996) · The Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a021313 · Cited by 145
Stress-induced secretion of growth inhibitors: a novel tumor suppressor function of p53
Komarova, E. A., Diatchenko, L. B., Rokhlin, O. W., Hill, J. E., Wang, Z. J., Krivokrysenko, V. I., Feinstein, E., & Gudkov, A. V. (1998) · Oncogene · doi:10.1038/sj.onc.1202303 · Cited by 140
Transcriptional activation of the human proliferating-cell nuclear antigen promoter by p53.
Morris, G. F., Bischoff, J. R., & Mathews, M. B. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.2.895 · Cited by 135
p53-dependent DNA damage-induced apoptosis requires Fas/APO-1-independent activation of CPP32beta.
Fuchs, E. J., Mckenna, K. A., & Bedi, A. (1997) · PubMed · Cited by 132
p53: A Cell Cycle Regulator Activated by DNA Damage
Selivanova, G., & Wiman, K. G. (1995) · Advances in cancer research · doi:10.1016/s0065-230x(08)60253-5 · Cited by 128
Cowan, D. B., Weisel, R. D., Williams, W. G., & Mickle, D. A. G. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)74196-9 · Cited by 126
Sun, Y., Hegamyer, G. A., & Colburn, N. H. (1994) · PubMed · Cited by 126
Self-citationWild-Type Human p53 Transactivates the Human Proliferating Cell Nuclear Antigen Promoter
Shivakumar, C. V., Brown, D. R., Deb, S., & Deb, S. P. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.12.6785 · Cited by 120
P53 activity is essential for normal development in Xenopus
Wallingford, J. B., Seufert, D. W., Virta, V. C., & Vize, P. D. (1997) · Current Biology · doi:10.1016/s0960-9822(06)00333-2 · Cited by 118
Analysis of p53 Mutants for Transcriptional Activity
Raycroft, L., Schmidt, J. R., Yoas, K., Hao, M., & Lozano, G. (1991) · Molecular and Cellular Biology · doi:10.1128/mcb.11.12.6067 · Cited by 113
Mirault, M.-É., Tremblay, A., Beaudoin, N., & Tremblay, M. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)54772-4 · Cited by 104
cDNA sequence coding for human glutathione peroxidase
Sukenaga, Y., Ishida, K., Takeda, T., & Takagi, K. (1987) · Nucleic Acids Research · doi:10.1093/nar/15.17.7178 · Cited by 100
Genetic analysis of cellular senescence
Vojta, P. J., & Barrett, J. C. (1995) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(95)00002-w · Cited by 95
Mullenbach, G. T., Tabrizi, A., Irvine, B. D., Bell, G. I., Tainer, J. A., & Hallewell, R. A. (1988) · Protein Engineering Design and Selection · doi:10.1093/protein/2.3.239 · Cited by 89
Bouck, N. (1996) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(96)00005-4 · Cited by 77
Sun, Y., Bian, J., Wang, Y., & Jacobs, C. (1997) · Oncogene · doi:10.1038/sj.onc.1200834 · Cited by 74
Self-citationMoscow, J. A., Morrow, C. S., He, R., Mullenbach, G. T., & Cowan, K. H. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42647-6 · Cited by 73
Transcriptional activation of the human S100A2 promoter by wild‐type p53
Tan, M., Heizmann, C. W., Guan, K., Schäfer, B. W., & Sun, Y. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)00135-0 · Cited by 70
Self-citationGoldsmith, M. E., Gudas, J. M., Schneider, E., & Cowan, K. H. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.4.1894 · Cited by 67
Lai, G., Moscow, J. A., Alvarez, M. G., Fojo, A. T., & Bates, S. E. (1991) · International Journal of Cancer · doi:10.1002/ijc.2910490511 · Cited by 64
Cowan, D. B. (1992) · Journal of Molecular and Cellular Cardiology · doi:10.1016/0022-2828(92)93196-q · Cited by 57
Bian, J., & Sun, Y. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.26.14753 · Cited by 57
Self-citationSun, Y., Dong, Z., Nakamura, K., & Colburn, N. H. (1993) · The FASEB Journal · doi:10.1096/fasebj.7.10.8344492 · Cited by 54
Self-citationSun, Y., Nakamura, K., Wendel, E. J., & Colburn, N. H. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.7.2827 · Cited by 54
Self-citationDiscrimination of DNA Binding Sites by Mutant p53 Proteins
Thukral, S. K., Lu, Y., Blain, G. C., Harvey, T. S., & Jacobsen, V. L. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.9.5196 · Cited by 48
Isolation and chromosomal localization of the human glutathione peroxidase gene
Chada, S., Beau, M. M. L., Casey, L., & Newburger, P. E. (1990) · Genomics · doi:10.1016/0888-7543(90)90566-d · Cited by 33
Bian, J., Jacobs, C., Wang, Y., & Sun, Y. (1996) · Carcinogenesis · doi:10.1093/carcin/17.12.2559 · Cited by 21
Self-citation
Cited by
Cellular response to oxidative stress: Signaling for suicide and survival*
Martindale, J. L., & Holbrook, N. J. (2002) · Journal of Cellular Physiology · doi:10.1002/jcp.10119 · Cited by 2,297
Lubos, E., Loscalzo, J., & Handy, D. E. (2011) · Antioxidants & Redox Signaling · doi:10.1089/ars.2010.3586 · Cited by 1,280
The antioxidant function of the p53 tumor suppressor
Sablina, A. A., Budanov, A. V., Ilyinskaya, G. V., Agapova, L. S., Kravchenko, J. E., & Chumakov, P. M. (2005) · Nature Medicine · doi:10.1038/nm1320 · Cited by 1,121
Vousden, K. H., & Ryan, K. M. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2715 · Cited by 959
ROS Generation and Antioxidant Defense Systems in Normal and Malignant Cells
Snezhkina, A. V., Kudryavtseva, A. V., Kardymon, O. L., Savvateeva, M. V., Melnikova, N. V., Krasnov, G. S., & Dmitriev, A. A. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/6175804 · Cited by 934
Metadata
- Authors
- Tan, M., Li, S., Swaroop, M., Guan, K., Oberley, L. W., & Sun, Y.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 1999-04
- Volume
- 274
- Issue
- 17
- Pages
- 12061-12066
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2152319713
- Cited by
- 253
- References
- 64
- FWCI
- 3.48
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.